Annual Total Debt
$510.55 M
+$395.38 M+343.30%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual total debt is $510.55 million, with the most recent change of +$395.38 million (+343.30%) on September 30, 2024.
- During the last 3 years, ARWR annual total debt has risen by +$485.01 million (+1898.64%).
- ARWR annual total debt is now at all-time high.
Performance
ARWR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$510.55 M
+$392.46 M+332.33%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly total debt is $510.55 million, with the most recent change of +$392.46 million (+332.33%) on September 30, 2024.
- Over the past year, ARWR quarterly total debt has increased by +$391.63 million (+329.33%).
- ARWR quarterly total debt is now at all-time high.
Performance
ARWR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ARWR Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +343.3% | +329.3% |
| 3 y3 years | +1898.6% | +1898.6% |
| 5 y5 years | +100.0% | +1898.6% |
ARWR Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1898.6% | at high | +1916.8% |
| 5 y | 5-year | at high | -100.0% | at high | +3340.6% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Arrowhead Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $510.55 M(+343.3%) | $510.55 M(+332.3%) |
| Jun 2024 | - | $118.09 M(-0.7%) |
| Mar 2024 | - | $118.92 M(+0.3%) |
| Dec 2023 | - | $118.58 M(+3.0%) |
| Sep 2023 | $115.17 M(+41.2%) | $115.17 M(+39.2%) |
| Jun 2023 | - | $82.73 M(-0.1%) |
| Mar 2023 | - | $82.78 M(+0.8%) |
| Dec 2022 | - | $82.13 M(+0.7%) |
| Sep 2022 | $81.58 M(+219.3%) | $81.58 M(+0.6%) |
| Jun 2022 | - | $81.11 M(+216.8%) |
| Mar 2022 | - | $25.61 M(+1.2%) |
| Dec 2021 | - | $25.32 M(-0.9%) |
| Sep 2021 | $25.55 M(+20.8%) | $25.55 M(+5.8%) |
| Jun 2021 | - | $24.14 M(+1.4%) |
| Mar 2021 | - | $23.80 M(+14.1%) |
| Dec 2020 | - | $20.87 M(-1.3%) |
| Sep 2020 | $21.14 M(>+9900.0%) | $21.14 M(-1.1%) |
| Jun 2020 | - | $21.37 M(+43.8%) |
| Mar 2020 | - | $14.87 M(+0.2%) |
| Dec 2019 | - | $14.84 M(>+9900.0%) |
| Sep 2019 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(-100.0%) |
| Sep 2018 | $2.33 M(-8.2%) | $2.33 M(-2.2%) |
| Jun 2018 | - | $2.38 M(-2.2%) |
| Mar 2018 | - | $2.43 M(-2.1%) |
| Dec 2017 | - | $2.48 M(-2.0%) |
| Sep 2017 | $2.53 M(-7.1%) | $2.53 M(-1.9%) |
| Jun 2017 | - | $2.58 M(-1.9%) |
| Mar 2017 | - | $2.63 M(-1.8%) |
| Dec 2016 | - | $2.68 M(-1.7%) |
| Sep 2016 | $2.73 M(+259.7%) | $2.73 M(-17.9%) |
| Jun 2016 | - | $3.32 M(+411.3%) |
| Mar 2016 | - | $650.00 K(-7.7%) |
| Dec 2015 | - | $704.20 K(-7.1%) |
| Sep 2015 | $758.30 K(-25.8%) | $758.30 K(-6.6%) |
| Jun 2015 | - | $812.20 K(-6.2%) |
| Mar 2015 | - | $865.80 K(-5.8%) |
| Dec 2014 | - | $919.20 K(-10.1%) |
| Sep 2014 | $1.02 M(-55.6%) | $1.02 M(-4.9%) |
| Jun 2014 | - | $1.08 M(-49.5%) |
| Mar 2014 | - | $2.13 M(-6.6%) |
| Dec 2013 | - | $2.28 M(-1.1%) |
| Sep 2013 | $2.30 M(-5.4%) | $2.30 M(-0.4%) |
| Jun 2013 | - | $2.31 M(-0.4%) |
| Mar 2013 | - | $2.32 M(-4.5%) |
| Dec 2012 | - | $2.43 M(-0.3%) |
| Sep 2012 | $2.44 M | $2.44 M(+4.0%) |
| Jun 2012 | - | $2.34 M(-0.3%) |
| Mar 2012 | - | $2.35 M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $2.36 M(+288.4%) |
| Sep 2011 | $606.80 K(+21.4%) | $606.80 K(+8.2%) |
| Jun 2011 | - | $560.90 K(+7.9%) |
| Mar 2011 | - | $519.70 K(+3.9%) |
| Dec 2010 | - | $500.00 K(0.0%) |
| Sep 2010 | $500.00 K(-59.2%) | $500.00 K(-13.0%) |
| Jun 2010 | - | $574.80 K(-27.8%) |
| Mar 2010 | - | $796.40 K(-21.4%) |
| Dec 2009 | - | $1.01 M(-17.4%) |
| Sep 2009 | $1.23 M(-20.2%) | $1.23 M(-14.5%) |
| Jun 2009 | - | $1.44 M(-60.7%) |
| Mar 2009 | - | $3.66 M(-5.2%) |
| Dec 2008 | - | $3.86 M(+150.9%) |
| Sep 2008 | $1.54 M(>+9900.0%) | $1.54 M(>+9900.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) |
| Sep 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sep 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sep 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sep 2003 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2003 | - | $629.50 K(-0.2%) |
| Mar 2003 | - | $630.50 K(-0.2%) |
| Dec 2002 | - | $632.00 K(-0.2%) |
| Sep 2002 | $633.50 K(+13.3%) | $633.50 K(-0.2%) |
| Jun 2002 | - | $635.00 K(+18.4%) |
| Mar 2002 | - | $536.50 K(-3.9%) |
| Dec 2001 | - | $558.00 K(-0.2%) |
| Sep 2001 | $559.00 K(-0.7%) | $559.00 K(-0.3%) |
| Jun 2001 | - | $560.50 K(-0.3%) |
| Mar 2001 | - | $562.00 K(-0.1%) |
| Dec 2000 | - | $562.50 K(-0.1%) |
| Sep 2000 | $563.00 K(-0.4%) | $563.00 K(-0.1%) |
| Jun 2000 | - | $563.50 K(-0.1%) |
| Mar 2000 | - | $564.00 K(-0.1%) |
| Dec 1999 | - | $564.50 K |
| Sep 1999 | $565.00 K(-47.2%) | - |
| Sep 1998 | $1.07 M(+4.5%) | - |
| Sep 1997 | $1.02 M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual total debt year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly total debt year-on-year change?
What is Arrowhead Pharmaceuticals annual total debt?
The current annual total debt of ARWR is $510.55 M
What is the all time high annual total debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total debt is $510.55 M
What is Arrowhead Pharmaceuticals annual total debt year-on-year change?
Over the past year, ARWR annual total debt has changed by +$395.38 M (+343.30%)
What is Arrowhead Pharmaceuticals quarterly total debt?
The current quarterly total debt of ARWR is $510.55 M
What is the all time high quarterly total debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total debt is $510.55 M
What is Arrowhead Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, ARWR quarterly total debt has changed by +$391.63 M (+329.33%)